For instance, the down-regulation of GPC3 expression increased the sensitivity of drug-resistant gastric cancer cells to mitoxantrone [90], and the knockdown of GPC3 increased the sensitivity of ovarian clear cell carcinoma cells to paclitaxel [86]. The gene discussed is GPC3; the disease is ovarian clear cell cancer.